Empiric Carbapenem Therapy for Sepsis: Are We Winning the Battle at the Expense of the War?

被引：0
|
作者：
Barletta, Jeffrey F. [1 ]
机构：
[1] Midwestern Univ, Coll Pharm, Dept Pharm Practice, Glendale Campus, Glendale, AZ 85308 USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 09期
关键词：
anti-bacterial agents; beta-lactams; carbapenems; sepsis; septic shock;
D O I：
10.1097/CCM.0000000000005949
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1275 / 1277
页数：3
相关论文
共 35 条
  • [21] Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae
    Liao, Yun
    Hu, Guang-Hui
    Xu, Yun-Fei
    Che, Jian-Ping
    Luo, Ming
    Zhang, Hai-Min
    Peng, Bo
    Yao, Xu-Dong
    Zheng, Jun-Hua
    Liu, Min
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 1003 - 1010
  • [22] Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality
    Diaz-Martin, Ana
    Luisa Martinez-Gonzalez, Maria
    Ferrer, Ricard
    Ortiz-Leyba, Carlos
    Piacentini, Enrique
    Jesus Lopez-Pueyo, Maria
    Martin-Loeches, Ignacio
    Levy, Mitchell M.
    Artigas, Antoni
    Garnacho-Montero, Jose
    CRITICAL CARE, 2012, 16 (06)
  • [23] Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study
    Cariou, Erwann
    Griffier, Romain
    Orieux, Arthur
    Silva, Stein
    Faguer, Stanislas
    Seguin, Thierry
    Nseir, Saad
    Canet, Emmanuel
    Desclaux, Arnaud
    Souweine, Bertrand
    Klouche, Kada
    Guisset, Olivier
    Pillot, Jerome
    Picard, Walter
    Saghi, Tahar
    Delobel, Pierre
    Gruson, Didier
    Prevel, Renaud
    Boyer, Alexandre
    ANNALS OF INTENSIVE CARE, 2023, 13 (01)
  • [24] Efficacy of carbapenem vs non carbapenem β-lactam therapy as empiric antimicrobial therapy in patients with extended-spectrum β-lactamase-producing Enterobacterales urinary septic shock: a propensity-weighted multicenter cohort study
    Erwann Cariou
    Romain Griffier
    Arthur Orieux
    Stein Silva
    Stanislas Faguer
    Thierry Seguin
    Saad Nseir
    Emmanuel Canet
    Arnaud Desclaux
    Bertrand Souweine
    Kada Klouche
    Olivier Guisset
    Jerome Pillot
    Walter Picard
    Tahar Saghi
    Pierre Delobel
    Didier Gruson
    Renaud Prevel
    Alexandre Boyer
    Annals of Intensive Care, 13
  • [25] Supportive Sepsis Therapy: Do we Use the wrong Target Value?
    Koehler, Dieter
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (06) : 439 - U101
  • [26] DOES IT MATTER IF WE GET IT RIGHT? IMPACT OF APPROPRIATENESS OF EMPIRIC ANTIMICROBIAL THERAPY AMONG SURGICAL PATIENTS
    Davies, Stephen W.
    Efird, Jimmy T.
    Guidry, Christopher A.
    Hranjec, Tjasa
    Metzger, Rosemarie
    Swenson, Brian R.
    Sawyer, Robert G.
    SHOCK, 2014, 42 (03): : 185 - 191
  • [27] Determinants of Inadequate Empiric Antimicrobial Therapy in ICU Sepsis Patients in Al-Madinah Al-Munawwarah, Saudi Arabia: A Comparison of Artificial Neural Network and Regression Analysis
    Dala Ali, Ahmad Habeeb Hattab
    Harun, Sabariah Noor
    Othman, Noordin
    Ibrahim, Baharudin
    Abdulbagi, Omer Elhag
    Abdullah, Ibrahim
    Ariffin, Indang Ariati
    ANTIBIOTICS-BASEL, 2023, 12 (08):
  • [28] Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy
    Karlowicz, MG
    Buescher, ES
    Surka, AE
    PEDIATRICS, 2000, 106 (06) : 1387 - 1390
  • [29] The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model
    Dinc, Gokcen
    Eren, Esma
    Kontas, Olgun
    Doganay, Mehmet
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (09) : 1739 - 1744
  • [30] The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model
    Gokcen Dinc
    Esma Eren
    Olgun Kontas
    Mehmet Doganay
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 1739 - 1744
1234